Moberg Pharma
Egetis attracts a bid and agrees to sell its priority review voucher, Lytix meets its endpoint in melanoma and Novo raises its outlook – the Nordic Pulse | 2026:45
Moberg Pharma strengthens potential with new US patent for MOB-015
Moberg Pharma has been granted a new US...
Bioteknik
Intervju
Zealand wins in obesity, Genmab hits first-line DLBCL and Oncopeptides crosses the blood-brain barrier – the Nordic Pulse | 2026:41
Demant raises the bar, XVIVO clears hearts and Zealand cashes in – the Nordic Pulse | 2026:33
Moberg Pharma builds momentum ahead of European launches
Moberg Pharma is gearing up for a broader...
Bioteknik
Intervju
Moberg Pharma siktar mot Kina med MOB-015
Samarbetet mellan Moberg Pharma och Karo Healthcare fortsätter...
Läkemedel
Moberg Pharma expanderar Karo-samarbetet till fyra nya marknader
Moberg Pharma säkrar ytterligare en leverantör för MOB-015
Moberg Pharma kommenterar licensavtalet med Karo Healthcare
Moberg Pharma har tagit ytterligare ett steg i...
Bioteknik
Premium
Moberg Pharma tecknar europeiskt licensavtal med Karo Healthcare
Två nya ledamöter föreslås till Moberg Pharmas styrelse
Moberg Pharma minskar ledningsgruppen
MARKET SIGNAL
ANALYS
Dagens nyhetssvep
Nyhetssvepet torsdag 12 november
NYHETSBREV
ANALYTICS
Nine of ten AstraZeneca analyst houses raised their targets after Q3
Sobi: eight analysts, eight raises – but three targets remain below the share price
Egetis attracts a bid and agrees to sell its priority review voucher, Lytix meets its endpoint in melanoma and Novo raises its outlook – the Nordic Pulse | 2026:45
Kommande event
MedTech Summit 2027
After a phenomenal debut last year, the premier gathering for medical technology is officially back. The response to our inaugural...
Global Forum 2027
Global Forum Returns for its 4th Edition. The premier networking event for Nordic life science companies, investors, and industry experts...
Investor Cardiometabolic Day
An exclusive boutique event in Copenhagen dedicated entirely to investors, C-level executives, and key leaders working within the cardiometabolic field....
Rekommenderat
Rekordförsäljning för RaySearch men marginalen pressas
Xbrane om FDA-godkännandet som öppnar USA för Lucamzi
Hansa om IND-ansökan för HNSA-5487 och utvalda PAES-resultat
AcuCort ur startblocken – siktar mot USA och svarta siffror
BioStock Investor Pitch: Biovica
Du är värd det bästa!
Lås upp vårt premium-innehåll: Bli prenumerant!
Skapa konto
